Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001393905-18-000324
Filing Date
2018-11-13
Accepted
2018-11-13 12:54:16
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ctbo_10q.htm 10-Q 232654
2 CERTIFICATION ctbo_ex311.htm EX-31.1 7641
3 CERTIFICATION ctbo_ex312.htm EX-31.2 7569
4 CERTIFICATION ctbo_ex321.htm EX-32.1 2406
5 CERTIFICATION ctbo_ex322.htm EX-32.2 2404
  Complete submission text file 0001393905-18-000324.txt   1483481

Data Files

Seq Description Document Type Size
6 ctbo-20180930.xml EX-101.INS 257360
7 ctbo-20180930.xsd EX-101.SCH 27454
8 ctbo-20180930_cal.xml EX-101.CAL 11170
9 ctbo-20180930_def.xml EX-101.DEF 56278
10 ctbo-20180930_lab.xml EX-101.LAB 106542
11 ctbo-20180930_pre.xml EX-101.PRE 111881
Mailing Address 1250 OAKMEAD PKWY SUNNYVALE CA 94085
Business Address 1250 OAKMEAD PKWY SUNNYVALE CA 94085 844-200-2826
Cantabio Pharmaceuticals Inc. (Filer) CIK: 0001550518 (see all company filings)

EIN.: 990373067 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54906 | Film No.: 181176771
SIC: 2834 Pharmaceutical Preparations